# EDGAR Filing Document

**Accession Number:** 0001702626
**File Stem:** 0001493152-23-007238
**Filing Date:** 2023-3
**Character Count:** 9589
**Document Hash:** 795a08c29dcd2b09eea2995823095789
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-007238.hdr.sgml**: 20230310

**ACCESSION NUMBER**: 0001493152-23-007238

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230308

**FILED AS OF DATE**: 20230310

**DATE AS OF CHANGE**: 20230310

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** APPELROUTH STEWART
- **CENTRAL INDEX KEY:** 0001702626

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-27072
- **FILM NUMBER:** 23723610

**MAIL ADDRESS:**
- **STREET 1:** 2117 SW HIGHWAY 484
- **CITY:** OCALA
- **STATE:** FL
- **ZIP:** 34473

**FORMER NAME:**
- **FORMER CONFORMED NAME:** Appelrouth Stewart
- **DATE OF NAME CHANGE:** 20170331
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AIM ImmunoTech Inc.
- **CENTRAL INDEX KEY:** 0000946644
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 520845822
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2117 SW HIGHWAY 484
- **CITY:** OCALA
- **STATE:** FL
- **ZIP:** 32801
- **BUSINESS PHONE:** 352-448-7797

**MAIL ADDRESS:**
- **STREET 1:** 2117 SW HIGHWAY 484
- **CITY:** OCALA
- **STATE:** FL
- **ZIP:** 32801

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEMISPHERX BIOPHARMA INC
- **DATE OF NAME CHANGE:** 19950614

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>APPELROUTH STEWART<br><sub>(Last) (First) (Middle)</sub><br>2117 SW HIGHWAY 484<br><sub>(Street)</sub><br>OCALA,, FL 34473<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-08 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>AIM ImmunoTech Inc. [ AIM ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-03-10 |  | J<sup>(5)</sup> |  | 68208 | D | 1.23<sup>(6)</sup> | 148855 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Options<sup>(1)</sup> | 29.48<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 143 |  | 2023-03-08 | 2027-04-30 | CommonStock | 143 | $0 | 143 | D |  |
| Options<sup>(1)</sup> | 28.16<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 150 |  | 2023-03-08 | 2027-05-15 | CommonStock | 150 | $0 | 150 | D |  |
| Options<sup>(1)</sup> | 25.96<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 163 |  | 2023-03-08 | 2027-05-31 | CommonStock | 163 | $0 | 163 | D |  |
| Options<sup>(1)</sup> | 21.56<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 196 |  | 2023-03-08 | 2027-06-15 | CommonStock | 196 | $0 | 196 | D |  |
| Options<sup>(1)</sup> | 21.56<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 196 |  | 2023-03-08 | 2027-06-30 | CommonStock | 196 | $0 | 196 | D |  |
| Options<sup>(1)</sup> | 21.12<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 250 |  | 2023-03-08 | 2027-07-15 | CommonStock | 250 | $0 | 250 | D |  |
| Options<sup>(1)</sup> | 18.48<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 287 |  | 2023-03-08 | 2027-07-31 | CommonStock | 287 | $0 | 287 | D |  |
| Options<sup>(1)</sup> | 18.04<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 295 |  | 2023-03-08 | 2027-08-15 | CommonStock | 295 | $0 | 295 | D |  |
| Options<sup>(1)</sup> | 15.84<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 338 |  | 2023-03-08 | 2027-08-31 | CommonStock | 338 | $0 | 338 | D |  |
| Options<sup>(1)</sup> | 16.28<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 2568 |  | 2023-03-08 | 2028-02-13 | CommonStock | 2568 | $0 | 2568 | D |  |
| Options<sup>(1)</sup> | 16.72<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 1136 |  | 2023-03-08 | 2028-04-12 | CommonStock | 1136 | $0 | 1136 | D |  |
| Options<sup>(1)</sup> | 13.20<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 1136 |  | 2023-03-08 | 2028-05-16 | CommonStock | 1136 | $0 | 1136 | D |  |
| Options<sup>(1)</sup> | 13.20<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 1728 |  | 2023-03-08 | 2028-05-16 | CommonStock | 1728 | $0 | 1728 | D |  |
| Options<sup>(1)</sup> | 13.64<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 1115 |  | 2023-03-08 | 2028-07-18 | CommonStock | 1115 | $0 | 1115 | D |  |
| Options<sup>(1)</sup> | 9.68<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 1963 |  | 2023-03-08 | 2028-10-17 | CommonStock | 1963 | $0 | 1963 | D |  |
| Options<sup>(1)</sup> | 9.68<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 11 |  | 2023-03-08 | 2028-11-14 | CommonStock | 11 | $0 | 11 | D |  |
| Options<sup>(1)</sup> | 9.68<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 2356 |  | 2023-03-08 | 2029-01-28 | CommonStock | 2356 | $0 | 2356 | D |  |
| Options<sup>(1)</sup> | 9.68<sup>(2)</sup> | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 568 |  | 2023-03-08 | 2029-01-28 | CommonStock | 568 | $0 | 568 | D |  |
| Options<sup>(1)</sup> | $2.77 | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 25000 |  | 2023-03-08 | 2030-08-12 | CommonStock | 25000 | $0 | 25000 | D |  |
| Options<sup>(1)</sup> | $1.71 | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 25000 |  | 2023-03-08 | 2031-11-11 | CommonStock | 25000 | $0 | 25000 | D |  |
| Options<sup>(1)</sup> | $0.70 | 2023-03-08<sup>(3)</sup> |  | J<sup>(4)</sup> |  | 25000 |  | 2023-03-08 | 2032-03-03 | CommonStock | 25000 | $0 | 25000 | D |  |

---

### Footnotes:

(1) Replacement for previously issued options.

(2) Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof.

(3) Date of re-issuance.

(4) Reporting person transferred options to former spouse in a matrimonial matter.

(5) Reporting person transferred common stock to former spouse in a matrimonial matter.

(6) Cost basis of the weighted average share price.

**Signature:** /s/ Stewart L. Appelrouth  
**Date:** 2023-03-10

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**